CA1270842A - 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs - Google Patents

5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs

Info

Publication number
CA1270842A
CA1270842A CA000595287A CA595287A CA1270842A CA 1270842 A CA1270842 A CA 1270842A CA 000595287 A CA000595287 A CA 000595287A CA 595287 A CA595287 A CA 595287A CA 1270842 A CA1270842 A CA 1270842A
Authority
CA
Canada
Prior art keywords
epoxy
solution
mmole
ether
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000595287A
Other languages
French (fr)
Inventor
Jagabandhu Das
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/736,628 external-priority patent/US4611005A/en
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Priority to CA000595287A priority Critical patent/CA1270842A/en
Application granted granted Critical
Publication of CA1270842A publication Critical patent/CA1270842A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ABSTRACT

A novel intermediate compound having the structure CH2-CH=CH-(CH2)m-CO2alkyl wherein X is -CH2-O , -CH2OH, -CHO or -CH=CH-?-R1 wherein m is 1 to 5, and R1 is lower alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl or lower alkenyl, is useful in the preparation of 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs having the structural formula CH2-CH=CH-(CH2)m-CO2R
wherein m is 1 to 5, R is H, lower alkyl, alkali metal or polyhydroxylamine, and R1 is lower alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl or lower alkenyl, which are themselves cardiovascular agents useful in the treatment of thrombotic disease.

Description

~.~7Q~

SUBSTITUTED PROSTAGLANDIN ANALOGS

The present invention relates to 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs which are cardiovascular agents useful, for example, in the treatment of thrombotic disease.
These compounds have the structural formula I * C~2 CH=CH-(CH2)m-CO2R
*)~/ 1 /* *
1/ ~ A-~-R
O *\ ¦ OH

and including all stereoisomers tAereof, wherein m is 1 to 5; R is hydrogen, lower alkyl, alkali metal salt or polyhydroxylamin~ salt; A is -C~=C~ or -(C~2)2-; and Rl is lower alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl or lower al~enyl.

7~ 8~

The present invention also includes intermediates for preparing the above compounds of the invention which have the structure IA ~ _CH2-CHo 1< 1 ~

0/ ~ \CH2-O
and IB ~ CH2-C~=C~-(cH2)m-cO
f~ 1 1/~\
O \ I X
O
wherein X is -CH2-O ~ , -CH2OH, -CHO or -C~=C~-C-Rl wherein m and Rl are as defined o above.
The term "lower alkyl" or "alkyl" as employed herein by itself or as part of a~other group includes both ~traight and branch~d chain radicals of up to 12 carbons, preferably 1 to 8 carbons, such as methyl, ethyl, propyl, isopropyl, butyl, t-butyl, isobutyl, pentyl, hexyl, heptyl, 4,4-dimethylpentyl, octyl, 2,2,4-trimetnylpentyl, nonyl, decyl, undecyl, dodecyl, the various 7~

-3~

branched chain isomers thereof, and the llke as well as such groups including a halo-substituent, such as F, Br, Cl or I or CF3, an alkoxy substi-tuent, an aryl substituent, an alkyl aryl substi-tuent, a haloaryl substituent, a cycloalkyl sub-stituent, an alkylcycloalkyl substituent, hydroxy, an alkylamir.o substituent, a nitro substituent, an amino substituent, a cyano substituent, a thiol substituent or an alkylthio sub-stituent.
The term "cycloalkyl" by itself or as part of another group includes saturated cyclic hydrocarbon groups containing 3 to 12 carbons, preferably 3 to 8 carbon~, which include cyclo-propyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclodecyl and cyclodo-decyl, any of which groups may be substituted with 1 or 2 halogens, 1 or 2 lower alkyl groups and/or lower alkoxy groups, an aryl group, 1 or 2 hydroxy groups, 1 or 2 alkylamino groups, 1 or 2 amino groups, 1 or 2 nitro groups, 1 or 2 cyano groups, 1 or 2 thiol groups or 1 or 2 alkylthio groups.
The term "aryl" or "Ar" as employed herein by itself or as part of another group refers to monocyclic or bicyclic aromatic groups containing from 6 to 10 carbons in the ring portion, such as phenyl, naphthyl, substituted phenyl or æubstituted naphthyl wherein the substituent on ei~her the phenyl or naphthyl may be 1 or 2 lower alkyl groups, 1 or 2 halogens (Cl, Br or F), an aryl group, 1 or 2 lower alkoxy groups, 1 or 2 hydroxy groups, 1 or 2 alkylamino groups, l or 2 amino groups, 1 or 2 nitxo groups, 1 7~

_4_ HA363 or 2 cyano groups, 1 or 2 thiol groups or 1 or 2 alkylthio groups~
The term "aralkyl", "aryl-alkyl" or "aryl-lower alkyl" as used herein by itself or a~
part of another group refers to lower alkyl groups as discussed above having an aryl substituent, such as benzyl.
The term "lower alkenyl" or "alkenyl"
includes straight or branched chain radicals of from 2 to 12 carbons, preferably 2 to 6 carbons in the normal chain, which include one double bond in the normal chain, such as ethenyl, 2-propenyl, 3-butenyl, 2-butenyl, 1-pentenyl, 3-pentenyl,
2-hexenyl, 3~hexenyl, 2-heptenyl, 3-heptenyl, 4~heptenyl, 3-octenyl, 3-nonenyl, 4-decenyl,
3-undecenyl, 4-dodecenyl and the like.
The term "lower alkoxy", "alkoxy" or "aralko~y" includes any of the above lower alkyl, alkyl or aralkyl groups linked to an oxygen atom.
The term "halogen" or "halo" as used herein refers to chlorine, bromine, fluorine or iodine with chlorine being preferred.
The term "polyhydroxylamine" refers to glucamine salt, tri(hydroxymethyl)aminomethane salt and the like.
The term "(CH2)m" includes a straight or branched chain radicals having from 1 to S carbons in the normal chain and may contain one or more lower alkyl or halo substituents. Examples of (C~)m groups include C~2, CH2CH2, (CH2)3, ( 2)g 0~

_5_ HA363 (~H3 ~H3 l H3 ~H3 C , CH-, -HC-CEI2 -, -C-CH2 -, ( CE12 ) ( CH

l H3 2 7' ( ~2)2 IH ~ -I-cH-, -cH2-cH--CH-cH2_, CH3 CE13 C~3 CH3 CH2 1~ C~2-CH-, and the like.

Preferred are those compounds of formula I
wherein A is CH=CH, and m is 2 or 4, R
is ~, and R1 is lower alkyl, aryl, such as phenyl, or aralkyl su~h as benzyl, or benzyl-l-methyl or cycloalkyl, sucb as cyclohexyl.
The various compounds of the invention may be prepared as outlined below.
The compounds of formula I of the invention - may be prepared as described below.
The starting compounds of the invention II
may be prepared as follows.
20Dione-A having the structure -- /~
~, O O

that is, 7-oxabicyclo~2.2.1]-5-heptene-2,3-dicarboxylic anhydride [Ber. 62, 554 (1929); Ann.
460, 98 (1928)], is reduced, for example, by ~7(~

reacting with lithium aluminum hydride or diisobutyl aluminum hydride in the presence of an inert organic solvent such as tetrahydrofuran, ether or toluene at reduced temperatures of from about -78C to about 67C to form diol B of the structure B ~ CH2-OH
10 <~

\ I C~I20E~ , The diol B is subjected to a chloroformylation reaction by reacting B dissolved in an inert organic solvent as described above, with phosgene in the presence of a solvent such as tetrahydrofuran, toluene, benzene or xylene, to form an alcohol of the structure C ~f ~2-0oC~Cl ~ ~
~\ I CH20H

The alcohol C is dissolved in an inert organic solvent such as methylene chloride, tetrahydrofuran or ether and then reacted with an organic base, such as pyridine, triethylamine, N,N-dimethyl-aminopyridine or diazabicycloundecane (DBU) at
4~

_7_ ~A363 reduced temperatures of from about ~78C to about 25 C, to form cyclic carbonate D

D ~\CH2 ~C=O

C~2 o The cyclic carbonate D is the~ subjected to alcoholysis by reacting D with.an alkanol (alkyl-O~) having from 1 to 12 carbons, such as ethanol, n-propanol, isopropanol, butanol, pentanol, hexanol, heptanol, octanol, nonenol or decanol, including all the various isomers thereof, preferably isopropyl alcohol, employing a molar ratio o~ ~:alkanol of within the range of from about l:10 to about 1:100 to form hydroxycarbonate E (which itself is a novel compound) E ~ C~2_o~

C~2-OIlOalkyl O O

(wherein alkyl contains 1 to 12 carbons a~ defined herein).
Thereafter, the hydroxy carbonate E is tosylated (or otherwise protected) by reacting E

lX7~

(dlssolved in methylene chloride, and a basic solvent such as pyridine~ triethylamine or dimethylaminopyridine) with tosyl chloride or other protecting agent, such as methane sulfonyl chloride (mesyl chloride) and trifluoromethanesulfonic anhydride, to form the tosylate F or other protected compound p ~ CH2-OTs (or other protect.ng group) ¦ C~2-OIO-alk O o Then, the tosylate F dissolved in an inert solvent such as dimethylsulfoxide, or dimethylformamide is cyanated by reacting F with an alkali metal ¦ cyanide such as NaCN or KCN employing a molar ratio of IV: cyanide of within the range of from about 1:1 to about 10:1, at elevated temperatures of from about 80C to about 130C, in an inert a~mosphere, such as an argon atmosphere, to form the cyano-carbonate G (which itself is a new compound) G ~ CH2-CN

2-o6o-alkyl 7~
~9_ HA363 Cyanocarbonate G is dissolved in an alcohol such as methanol or ethanol and treated with aqueous alkali metal carbonate such as potassium carbonate at reduced temperature to form cyano-alcohol H

10 \ ~
\ I CH2 ~

which is made to undergo tetrahydropyranyl ether formation by reacting cyano alcohol H with dihydropyran in the presence o~ an inert organic solvent such as ~ethylene chloride or ether and catalytic amount of p-toluene sulfonic acid at reduced temperatures of from about 0C to about 10C, to form the tetrahydropyranyl ether of formula J

~ ~ C~2-CN
~ ~

~ \ C~2 O I ,_, O~

Compound J is then made to undergo epoxide formation by treating a solution of J in methylene 7~

chloride or other appropriate solvent with m-chloroperoxybenzoic acid at reduced temperatures to form epoxy nitrile II ~which itself is a novel compound) II ~ C~2-CN

/ ~ ~2- ~

(which is a novel compound).

The compounds of formula I of the invention may be formed starting with compound II in accordance with the following reaction sequence.

~70~4~

_, .

~ T ,, _~
~ N U Ç

0 y ~0 ~ U
~,0 a a~ ~ ~

T~ , D"~o~

~o~

_ 12- HA36 3 8~ ~
C
_, ~
o X
U o _, .Y g ' e 3~

_ 13 HA363 N ,~ ~ ~ X

0 3: 1 1~ ~ ~ c~ o :S~ ~ X

~3 ~o G
,0 ,GO

Z ~ C~
C~

O=c~
0=~
~ ~ I

+
~ .

~7~V~

_ 14- HA363 O
~o t o ~ ~ .
~, O X

7~

-15~

As seen from the reaction sequence set out above, compounds of the invention may be formed by treating II with diisobutyl aluminum hydride (DIBAL~ in the presence of an inert solvent such a~ toluene or tetrahydrofuran at reduced temperatures of from about -70 to about -85C to form epoxy aldehyde III (which itself is a new compound) III ~ ,CH2-CHO

I /~\C~20 {~
O

Epoxy aldehyde III in appropriate solvent such as tetrahydrofuran is then reacted with a suspension formed by mixing dry carboxyalkyltri-phenylphosphonium halide K

K + B -(CH ) COOH

in tetrahydrofuran with potassium t-amylate in toluene at reduced temperature and the reaction product treated with ethereal diazoalkane to form the ester IV (which also is a novel compound) 4~

. -16-IV ~ ~ C~ (C~z)m-COOR

(wherein R is lower alkyl) Compound IV is dissolved in methanol and is then hydrolyzed by treatment with strong acid such as ~Cl, Amberlyst resin or acetic acid to form alcohol v (which also is a novel compound) V ~ C~2 C~ OE-(c~)~-cozR

O ¦ C~2-OH
O

(wherein R is lower alkyl) which also is a novel compound.
The epoxy ester V containing the hydroxy-methyl group is used to form epoxy aldehyde VI
by subjecting epoxy ester V to Collins oxidation, for e~ample, by reacting V with chromium oxide in pyridine.
Aldehyde VI of the structure * Trade Mark 7~

VI ~ ~2 C~ ~H-~c~2)m-cooR

S ~o wherein R is lower alkyl (which also is a novel compound) is reacted with a dialkoxy phosphonate, such as of the structure O O
L (C~30)2P-CH2-~-R1 employing a molar ratio of V:L of within the range of from about 1:1 to about O.5:1, under ba~ic conditions, such as triethylamine, diazabicyclo undecene (DBu~ in the presence of ZO anhydrous lithium bromide and an inert organic solvent, such as methylene chloride or acetonitrile to form epoxy compound VII of the structure VII ~ C~2 C~ C'-(C~2)~-COOR

O ¦ C~-C~ R
O
(wherein R is lower alkyl) l~t:~lU8~,4 H~3 63 which also is a novel compound.
Compound VI I may then be reduced by two different ways as outlined above to form compounds of the invention VI I I or IX

~CH2 -CH=CH- ( CH ~ -COOR
/~

0 ~ I A-CH-Rl o OH

(wherein R is lower alkyl) VIII - A is (CH2)2 IX - A is -CH=CH-or compounds of the invention of the general formula X

X ~ C112-CE=CH-(C1}2)m-COOR

2 5 0 ¦ A-CH-R
0 0~

(wherein R is lower alkyl) Compounds of formula I

7~4~

-;L9-IA /\~ CH2-CH=CH- ( CH2 )m-COOR
5 \
` ~ I A-CH-R

(wherein R is hydrogen) ld may be prepared by hydrolyzing ester VIII or IX by treatment with a strong base such as sodium hydroxide or lithium hydroxide in the presence of an iner~ solvent such as tetrahydrofuran, methanol or dimethoxyethane-water to form the corresponding alkali metal salt which iæ the~ treated with strong acid such as ~Cl to for~ the acid compound of the i~vention IF.
The compounds of this invention have seven centers of asymmetry as indicated by the asterisks in formula I. However, it will be apparent that each of the formulae set out above which do not include asterisks still represent all of the possible stereoisomers thereof. All of the various stereoisomeric forms are within the scope of the invention.
The various stereoisomeric forms of the compounds of the invention, namely, cis-exo, cis-endo and all trans forms and stereoisomeric pairs may be prepared as shown in the working Examples which follow and by employing starting materials and following the procedures as outlined ~7~

in U. S. Patent No. 4,143,054. Examples of such stereoisomers are set out below.

Ia f 2 CH CH-(CH2)m-CO
~ H

J\~ A_CH_Rl (cis-endo) Ib ~ --CH2-CH=CH-(CH2) -CO R

O \ I I .

OH

(cis-exo~

~27~

Ic CH2-C~=C~I- ( C~2 ) -C02R

0~ gH
O ~

~trans) Id C~2-C~-CH-(CH2)m-CO2R

~ --H

O A-SCH-R
OH

(trans) The wavy line ~ 5 ) in the ~bove formulae indicates that the hydroxy group in each of the compounds of formulae Ia-Id is either R(~) or S~
The nucleus in each of the compounds of the invention is depicted as ~: 7C~1 ~ t~, S 0~

for matter of co~venience; it will also be appre~-iated that the nucleus in the compou~ds of the invention may be depicted as ~1' The compounds of this invention are cardiovascular agents useful as platelet aggre-gation inhibitors, such as inhibiting arachidonic acid-induced platelet aggregation (e.g., for treatment of thrombotic disease, such as coronary or cerebral thromboses) and in inhibiting broncho-constriction as induced by asthma. They are also selective thromboxane A2 receptor antagonists and synthetase inhibitors, e.g., having a vasodilatory effect for treatment of myocardial ischemic disease, such as angina pectoris.
The compounds of this invention may also be used in combination wi~h a-cyclic AMP phosphodi-esterase (PDE) inhibitox such as theophylline orpapaverine in the preparation and storage of platelet conc~ntrates.

H~363 The compounds of the invention can be administered orally or parenterally to various mammalian species known to be subject to such maladles, e.g., humans, cats, dogs, and the like in an effective amount wi~hin the dosage range of about 1 to 100 mg/kg, preferably about 1 to 50 mg/kg and especially about 2 to 25 mg/kg on a regimen in single or 2 to 4 divided daily doses.
The compounds of the invention may also be 10 administered topically to any of the above mammalian species in amounts of from about 0.1 to 10 mg/kg in single or 2 to 4 divided daily doses.
The active substance can be utilized in a composition such as tablet, capsule, solution or suspension containing about 5 to about 500 mg per unit of dosage of a compound or mixture of compounds of formula I. They may be compounded in conventional matter with a physiologically acceptablo vehicle or carrier, excipient, binder, preservative, stabilizer, flavor, etc. as called for by accepted pharmaceutical practice. Also as indicated in the discussion above, certain members additionally serve as intermediates for other members of the group.

~'7~

The following Examples represent preferred embodiments of the invention. Unless otherwise indicated, all temperatures are expressed in degrees Centigrade.

Example 1 [1~,2~(5Z),3~(1E,35),4a,5~,6a]-7-[5,6-Epoxy-3-(3-hydroxy-l-octenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5 he~tenoic acid,_methYl ester A. 7-Oxabicyclo[2.2.1]-5-hepten-2,3-dimethanol To a suspension of 6.84 g of lithium aluminum hydride (180 mmol) in 200 ml of freshly distilled T~F, cooled in an ice-water bath was added dropwise, a solution of 20 g of 7-oxabicyclo[2.2.1~-5-heptene-2,3-dic~rboxylic anhydride (120 mmol) in 150 ml o~ dry THF, over a period of 1 hour. After the addition, the cooling bath was removed and the reaction mixture was stirred at room temperature for 24 hours. The reaction mixture was now cooled in an ice-water bath and excess of hydride was destroyed by slow addition of freshly prepared saturated sodium sulfate solution. Addition was continued until all the inorganic salts were precipitated as white granular solids. Anhydrous magnesiu~ sulfate was added to the reaction mixture and it was fil~ered.
~ The residue was thoroughly washed with m~thylene chloride. The residue was taken up in 500 ml of 10% acetonitrile in ethyl acetate, stirred for 30 minutes and finally was filtered. The combined filtrate was concentrated under reduced pressure.
The crude residue was chromatographed on a silica 7~3~

HA3~3 _ ~I S _ gel column. Elution with 50% ethyl acetate in hexane followed by ethyl acetate and finally with 10% methanol in ethyl acetate afforded 17.25 g of title diol as a colorless viscous oil.

B . 7 -oxabicyclot2~2~ 5-heptene-2~3 dimethanol carbonate .. . . _ _ To a solution of 16.73 g of Part A diol (107.4 m~ole) in 200 ml of freshly distilled THF, cooled in an ice-water bath was added dropwise 90 ml of a 12.5% by weight solution of phosgene in toluene (112.5 mmol), over a period of 45 minutesO
The reaction mixture was stirred for an additional 15 minutes, whereupon argon was bubbled through to remove excess of phosgene and hydrogen chloride formed during ~he reaction. The reaction mixture was now concentrated under reduced pressure. The crude monochloroformate was now dissolved in 250 ml of methylene chloride and cooled at -50C in a dry ice-acetone bath. A solution of 25 ml of pyridine in 50 ml of methylene chloride was now added dropwise over a period of 20 minutes. An immediate white precipitate was formed upon addition. .The reation mixture was left at -50C for an additional 30 minutes, whereupon the cooling bath was removed and the reaction mixture was washed thoroughly with water. The methylene chloride layer was dried over anhydrous magnesium sulfate, filtered and the filtrate was concentrated u~der reduced pressure. The crude residue was triturated with ether, cooled at 0C and the precipitated title carbonate was filtered off. 15.25 g of white crystalline title carbonate was obtained.

7(~

H~363 C. 2-Hydroxymethyl-3-isopropyloxycarbonyl-ox~ yl-7-oxablcyclo[2.2.11hePtene To a suspension of 15.25 g of Part B cyclic carbonate (83.8 mmole) in 200 ml of isopropyl alcohol was added with stirring 1 g of p-toluene sulfonic acid. The reaction mixture was heated under reflux for 8 hours whereupon it was cooled and isopropanol was removed by distillation under reduced pressure. The crude residue was dissolved in methylene chloride and washed with aqueous sodium bicarbonate solution. The aqueous layer was extracted several times wi~h methylene chloride. The combined methylene chloride extract was dried over anhydrous magnesium sulfate and was then concentrated under reduced pxessure to obtain 22.53 g of title isopropyloxycarbonate as a viscous oil.

D. 2-p-Toluenesulfonyloxymethyl-3-isopro-pyloxycarbonyloxymethyl-7-oxabicyclo-[2.2.11heptene To a solution of 22.53 g of Part C isopropyl-oxycarbonate ~84 mmole) in 100 ml of pyridine was added with stirring 19.2 g of p-toluene sulfonyl chloride ~101 m~ole) at 0-5C. The reaction ~ixture was stirred at room temperature for 24 hours, whereupon it was diluted with methylene chloride and washed thoroughly with water, saturated copper sulfate solution and finally with water. The combined aqueous layer was extracted with two 200 ml portions of methylene chloride.
The combined methylene chloride extract was dried over anhydrous magnesium ~ulfate and finally was concentrated under reduced pressure. The crude residue was ~riturated with ether, cooled at 0C
and the precipitate title tosylate (28.3 g) was filtered off. The mother liquor was concentrated and chromatographed on a silica gel column to obtain additional 5.2 g of crystalline title tosylate (eluting solvent 15-30% ethyl acetate in hexane).

E. 2-Cyanomethyl-3-isopropyloxycarbonyl-oxym~t~ --abicYclo[2~2. 11 he~tene To a solution of 5.3 g ~f Part D tosylate (12.99 mmole) in 50 ml of dry dimethylsulfoxide was added with stirring 1.28 g of powdered sodium cyanide (26 mmole). The reaction mixture was placed on an oil bath (bath temperature 90-95~C) and heated for 2 hours. It was now cooled and diluted with 200 ml of ether. The reaction mixture was now thoroughly washed with water. The combined aqueous extract was extracted with two 150 ml of ether. The ether layer was now dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The crude residue was chromatographed on a silica gel column. Elution with 25-50% ehtyl acetate in hexane afforded 2.58 g of title cyano-carbonate.

F. 2-Cyanomethyl-3-hyro~ymethyl-7-oxabi-c~clo[2.2.1lheptene To a solution of 1 g of potassium carbonate in 25 ml of water and 75 ml of methanol, cooled in an ice-water bath was added with stirring a solution of 2.58 g of Part E cyano-carbonate (9.8 ~mol) in 10 ml of methanol. After 15 minutes, the cooling bath was remo~ed and the reaction mixture was allowed to stand at room temperature for additional 6 hours, whereupon it was acidified with lN a~ueous hydrochloric acid ~olution. Most of methanol was now removed by distillation under reduced pre sure. The residue was now exhaustively extracted with methylene chloride (X12) (after saturating it with sodium chloride).
The combined organic extract was dried over anhydrous magnesium sulfate and concentrat~d under reduced pressure. The crude residue was chromatographed on a silica gel column and eluted with 25-50% ethyl acetate in hexane, followed by ethyl acetate to obtain 1.23 g of title cyano alcohol.

G. 2-Cyanomethyl-3-tetrahydropyranyloxy-methyl-7-oxabicyclo~2.2.1Lhe~tene A solution of 1.23 g of Part F
cyano-alcohol (7.36 mmole) in 20 ml of dry methylene chloride was treated with 800 ml of dihydropyran (8.89 mmole) and catalytic amount of p-toluene sulfonic acid at 0-5C. After 4 hours, the reaction mixture was diluted with ether and washed with agueous sodium bicarbonate solution.
The aqueous layer was reextracted twice with ether. The com~ined organic extract was dried over anhydrous magnesium sulfate and concentrated - 30 under reduced pressure. The crude residue was chromatographed on a silica gel column and eluted with 20-25% ~thyl acetate in hexane to obtain 1.61 g of title tetrahydropyranyl ether.

~7(3B4 --2g--H. 5,6-Epoxy-2~cyanomethyl-3-tetrahydro-pyranyloxymethyl-7-oxabicyclo[2.2.1]-heDtene ~ solution of 1.61 g of Part G cyano ether (6.4 mmole) in 20 ml of dry methylene chloride wastreated with 1.66 g of 80% pure m-chloroperoxy-benzoic acid (9.6 mmole) at 0-5C. After a few minutes, the cooling-bath was removed and the reaction mixture was let stand at room temperature for 6 hour~. The reaction mixture was now diluted with ether and excess of peracid was decomposed by addition of aqueous sodium met~-bisulite solution. After stirri~g for 30 minutes, the organic layer was separated and the aqueous layer was extracted twice with methylene chloride. The combined organic extract was dried over anhydrous magnesium sulfate and co~centrated under reduced pressure. Purification by chromatography on a silica gel column (eluting solvent 25-67% ethyl acetate in hexane) afforded 1.57 g of title epoxide.

J. 5,6-Epoxy-2-formylmethyl-3-tetrahydro-pyranyloxymethyl-7-oxabicyclo~2.2.1]-heDtene To a solution of Part ~ epoxy-nitrile (1.57 g, 5.88 mmole) in 25 ml of toluene, cooled at -78C in a dry ice-acetone bath was added with stirring, 6.8 ml of a 25% by weight solu~ion of diisobutylaluminum hydride in toluene (~12 mmole), dropwise over a period of 5 minutes. After 4 hours at -78C, excess of hydride was destroyed by dropwise addition of 1 ml of glacial acetic acid.
The cooling bath was removed and 20 g of silica 1~7~3~

gel was added to the reaction mixture with stirring, followed by 1.5 ml of water dropwise.
Stirring was continued for 30 minutes, whereupon the reaction mixture was filtered and the residual silica gel was washed successively with THF, 5%
acetonitrile in ethyl acetate and finally with acetone. The combined filtrate was concentrated under reduced pressure and the crude residue was chromatographed on a silica gel column. Elution with 50% ethyl acetate in hexane, followed by ethyl acetate afforded 1.16 g of title epoxyaldehyde which crystallized on standing at -20C.

K. [la,2~(5Z~,3~,4a,5~,6a]-7~[5,6-Epoxy-3-(tetrahydropyranyloxymethyl)-7-oxabi-cyclo[2.2.1]hept-2-yl]-S-heptenoic acid, methYl ester A suspension of 5.77 g of freshly dried carboxybutyltriphenylphosphonium bromide (13.03 mmol), in 50 ml of freshly distilled THF, cooled in an ice-water bath was trea~ed dropwise with 12 ml of a l.S M solution of K-t-amylate in toluene (19.2 mmole~. The yellow-orange suspension was stirred at 0C for 30 minutes and finally at room temperature for 1 hour, whereupon it was cooled to -20C and a solution of 2.33 g of Part J epoxy aldehyde (8.69 mmole) in 10 ml of dry L~ was added dropwise over a period of several minutes.
An instant discolorization of the ylide solution was observed. The reaction mixture was stirred at -20C for 2 hours, whereupon it was warmed to 0C
and left for 15 minutes, prior to addition of 1~7~*~

-31~

glacial acetic acld. The reaction mixture was now dil~ted with ether and washed wlth water. The ether extract was washed several times with saturated sodium bicarbonate solution. The combined aqueous extract was now washed with ether (X2). The agueous layer was now carefully acidified with lN aqueous hydrochloric acid to p~
2. It was now extracted with ether and then with methylene chloride. The combined ether and methylene chloride extract was dried over anhydro-ls magnesium sulfate and concentated under reduced pressure. The crud~ residue was diluted with 75 ml of e~her, cooled in an ice-water bath and an etheral diazomethane solution was added dropwise until the color persisted. After 30 minutes, excess diazomethane was removed by bubbling ar~on through the reaction mixture. It was now concentrated and the crude residue was chromatographed on a silica gel column. Elution with 15-40% ethyl acetate in hexane afforded 1.27 ~ of title SZ-ester (contaminated with 10-15% of undesired 5E ester).

L. [la,2~(5Z),3~,4a,5a,6a]-7-[5,6-Epoxy-3-hydroxymethyl-7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid, methYl ester To a solution of 1.27 g of Part K tetrahydro-pyranyl ether (3.46 mmole) in 30 ml of methanol was added with stirring 250 mg of powdered and dried Amberlyst-15. After 6 hours at room temperature, the reaction mixture was diluted with ether and anhydrous magnesium sulfate was added.

E ~

~A~63 It was now filtered and ~e residual solid w~s washe~ thoroughly wi~h ethe~. The combined organic e~tract W2S drie~ over anhydrous maSnesium sulfate a~d conce~tratad under reduced pressure S The crude residue was c.~romatographed on a silica gel colu~n and eluted with 50-75% e~hyl acetate ln hexane to obtain 892 mg of title alcohol ester.

M. [la,2~(5Z),3~,4a,5a,6a]-7-r5,6-Epo~y-3-formyl-7-~abicyclo[2.2.~]~
hept-2-yL]-5-heptenoic acid, methyl ester To a suspeQsion of 325 mg of pyridinium chl~rochromate and 325 mg of Celite in 20 ml of dry m~thylene chloride was added wi~h stirrlng a solutlon of 211 mg Part L alco~ol ester (O.75 mmole) in 2 ml of methylene chloride. A~te_ 4 hours at room te~perature, the reaction mixture was diluted with 100 ml of ether and filte_ed through a pad of Florisil. Florisil was washed se~Jeral times with ether and ethyl acetate. The com~ined organic e~tract was washed with water, dried over anhydrous maqnesium sulfate and was then conce~trated under reduced pressure to obtain 174 mg of title aldehyde.

N, [la,2~(5Z),3~(1E),4~,5a,6a]-7-[5,6-Epoxy-~-(3-oxo-1-octe~yl)-7~
oxabicyclo[2.2.1]he~t-2-yl]-5-he~tenoic acid, methvl ester To a suspension of 90 mg of dry li~hium ~romide in 5 ml of dry methylene chloride was added with stirring lao ~1 of t~iethylamine, * Trade Mark 7~4~

followed by a solution of .222 mg dimethyl-(2-oxoheptyl3 phosphona~e (1 mmole) in 1 ml of methylene chloride. After stirring for 15 minutes at room temperature, a solution of 174 mg Part M
aldehyde (O.6~ mmole) in 3 ml of methylene chloride was added dxopwise. The reaction was stirre~ overnight, whereupon it was diluted with ether and wa~hed with water. The aqueous layer was e~txacted with ether (X2). The combined ether extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The crude oily residue was chromatographed on a silica gel column and eluted with 15-30% ethyl acetate in hexane to obtain 175 mg of title enone.
O. [1~,2~(5Z),3~(1E,3S~,4a,5a,6a]-7-~5,6-Epoxy-3-(3-hydroxy-1-octenyl)-7-oxabi-cyclo[2.2.1]hep~-2-yl]-5-heptenoic acid, methy ~ fast movinq isomer ?
and P. ~la,2~5Z),3~(1E,3R),4a,5a,6a]-7-[5,6-Epoxy-3-(3-hydroxy-1-octenyl)~7-oxabi-cyclo[2.2.1]hept-2-yl]-5-heptenoic - acid, methyl ester (slow movinq isomer) To a solution of 170 mg of Part N enone (0.45 mmole3 in 5 ml of methanol and 'l'~k' each, was added with stirring 170 mg of ceric chloride hydrate. Aftex 10 minutes at room temperature, the homogeneous solution was cooled to -50C in a dry ice-acetone bath and 20 mg of solid sodium boro hydride (O.5 mmole) was added. The reaction mixture was stirred at -50C for 1 hour, whereupon it was treated with aqueous ammonium chloride 3~

-3~-solution. The cooling bath was removed and the reaction mixture was diluted with ether. The organic layer was separated and the aqueous layer was reextracted successively with ether and methylene cloride. The combined organic extract was dried over anhydrous magnesium sulfate and concentrated. Purification by chromatography on a silica gel column and elution with 30-50% ethyl acetate in hexane afforded 130 mg of title lo fast-moving alcohol epimer and 40 mg of slow-moving isomer.

Example 2 [la,2~(5Z),3~(1E,3S~,4a,5a,6a]-7-[5,6-Epoxy-3-(3-hydroxy-1-octenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-S-heE~enoic acld (fast movinq ester) A soiution of 130 mg of Example 1 fast-moving alcohol epimer (0.35 mmole) in 5 ml of distilled TKF was treated with 2 ml of a lN
aqueous lithium hydroxide solution. ~fter 8 hours at room temperature, the reaction mixture was diluted with ether and acidified to pH 1 by addition of lN aqueous hydrochloric acid solution. The ether layer was separated and the aqueous layer was extracted with methylene chloride (X2). The combined organic extract was dried over anhydrous magnesium sulf~e and concentrated under reduced pressure to obtain 120 mg o~ crude acid (contaminated with 10 15% of presumably SE-isomer~. Chromatography on a silica gel column and elution with 2-3% methanol in methylene chloride afforded 8~ mg of pure title acid.

7~

21H325 C, 69.20; H, 8.85 Found: C, 69.24; H, 8.84 Example 3 [la,2~(5Z3,3~(1E,3R),4a,5a,6a]-7-[5,6-Epoxy-3-(3-hydroxy-l-octenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (slow movin isomer? _ To a solution of 40 mg [la,2~(5Z),3~(lE,35),-4a, 5a, 6a ] -7-[5,6-epoxy-3-(3-hydroxy-octenyl)-7-oxabicyclo~2.2.1]hept-2-yl3 S-heptenoic acid, methyl ester slow-moving alcohol epimer (prepared as described in Example 1 Part P~ (O.11 mmole~ in 3 ml of distilled THF was added with stirring 1 ml of a lN aqueou~ lithium hydroxide solution. After 8 hours at room temperature, the reaction mixture was diluted with ether and acidified with lN
aqueous hydrochloric acid solution of p~ 1.
The organic layer was separated and th~ agueous layer was extracted with methylene chloride. The combined organic extract was dried with anhydrous magnesium sulfate and then concentrated under reduced pressure to obtain 33 mg of title acid as an oil.

lcd for C~lH32O5, 0.96 mole of ~2 C, 66.06; ~, 8.95 Found: C, 66.06: ~, 8.47 Exam~le 4 [la,2~(5Z),3~1E,35),4a,5a,6a]-7-~5,6-Epoxy-3-(3-cyclohexyl-3-hydroxy-1-propenyl)-7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid (fast moving isomer~
.

7~

A. [la,2~5Z),3~(1E),4a,5a,6a]-7-[5,6-Epoxy-3-(3-oxo-3-cyclohexyl-1-propenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester To a suspension of 135 mg of dry lithium bromide in 5 ml of methylene chloride was added with stirring 200 ~1 of triethylamine, followed by a sol!tion of 350 mg 2-oxo-cyclohexyl(dimethyl)-phosphonate (1.5 mmole) in 2 ml of methylene chloride. After stirring for 15 minutes at room temperature, a solution of 220 mg of [la,2~(5Z),-3~(1E,35),4a,5a,6a]-7-t5,6-epoxy-3-formyl-7-o~ybicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester prepared as described in Example 1 lS Part M in 3 ml of methylene chloride was added dropwise. The reaction mixture was stirred at room temperature for 3 hours whereupon it was diluted with ether and washed with water. The aqueous layer was extracted with ether (X2). The 20 combined ether eXtraCt was dried over anhydrous magnesium sulfate and was then concentrated under reduced pressure. Chromatographic purification on a silica gel column (eluting solvent 10-30% ethyl acetate in hexane) gave 235 mg of desired title 25 enone~

B. tla,2~(5Z),3~(1E,3S),4a,5a,6a]-7-[5,6-Epoxy-3-(3-cyclohexyl-3-hydroxy~
propenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester ( fas~
movinq isomer) and 7(~

C. ~1~,2~5Z),3~(1E,3R~,4~,5~,6~]-7 [5,6-Epoxy~3 (3-cyclohexyl-3-hydroxy-1-propenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester (slow movinq isomer) _ _ To a solution of 235 mg of Part A enone (O.61 mmole) in 5 ml of methanol and THF was added with stirring 235 mg ceric (111) chloride hydrate. After stirring or 10 minutes at room temperature, the reaction mixture was cooled to -50C and 25 mg of solid sodium borohydride (O.66 mmole~ was added. After 1 hour at -50C, the reaction mlxture was quenched b~ addition of aqueous ammonium chloride solution. It was now warmed to room temperature and diluted with ether. The organic layer was separated and the agueous layer was extracted with methylene chloride. The combined organic extract was dried over anhyd~ous magnesium sulfate and concentrated under reduced pressure. The crude residue was chromatographed on a silica gel column and eluted with 30-67% ethyl acetate in hexane to obtain 175 mg of title B fast-moving alcohol epimer and 35 mg of title C slow-moving alcohol epimer.
ExamPle 5 [1,2,B(5Z),3~(1E,3S),4a,5~,6a]-7-t5,6-Epoxy-3-(3-cyclohexyl-3-hydroxy-1-propenyl)-7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid (fast moving isomer~ _ A solution of 175 mg of Example 4, Part B, alcohol-ester (fast moving isomer) in 5 ml of dry THF was treated with 2 ml of lN aqueous lithium 7~4~

hydroxide solution. The reaction mixture was stirred at room temperature for 8 hours, whereupon it was acidified with lN aqueous hydrochloric acid solution. It was then diluted with ether and the organic layer was separated. The aqueous layer was extracted with methylene chloride twice. The combined organic extract was dried over anhydrous magnesium sulfate and was then concentrated under reduced pressure to obtain 163 mg of crude acid.
Chromatography on a silica gel colum~ and elution with 3-5% methanol in methylene chloride afforded 110 mg of title acid.

Anal Calcd for C22H325 C~ 70-18; H~ 8-57 Found: C, 70.03; H, 8.59 Example 6 [la,2~(5Z),3~(1E,3R),4a,5~,6a]-7-[5,6-Epoxy-3-(3-cyclohexyl-3~hydroxy-1-propenyl) 7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid (slow moving isomer~
, To a solution of 35 mg Example 4 Part C
slow-moving alcohol epimer (O.09 mmole) in 3 ml of distilled THF was added with stirring 1 ml of a lN
aqueous lithium hydroxide solution. After 8 hours at room temperature, the reaction mixture was diluted with ether and acidified to p~ 1 with lN aqueous hydrochloric acid solution. The organic layer was separated and the aqueous layer was extracted with methylene chloride. The combined organic extract was dried over anhydrous magnesium sulfate and finally was concentrated ~7~4~

-under reduced pressure to obtain 28 mg of title acid.

22 32 5~ 27 mole of water C, 69.28; H, 8.60 Found: C, 69.28; H, 8.71 Example 7 [la,2~(5Z),3~(1E,3R,4S),4a,5a,6~Y]-7-t5,6-Epoxy-10 3 (3-hydroxy-4-phenyl-1-pentenyl)-7-oxabicyclo-[2.2.1~he~t-2-yll-5-he~t noic acid, methyl ester A. [la,2~(5Z~,3~(1E,3R,4S),4a,5~,6aJ-7-[5,6-Epoxy- L 3-(3~oxo-4-phenyl-l-! pentenyl)-7-oxabicy~1O[2.2.1]hept-2-yllL-5-he~tenoic acid, methyl e~ter To a suspension of 90 mg of anhydrous lithium bromide 51 mmole) in 5 ml of dry methylene chloride was added with stirring 140 ~l triethyl-amine (1 mmole). 256 mg of (+) dimethyl(2-oxo-3-methyl-3-phenyl) propyl phosphonate was then added dropwise. After 15 minutes at room temperature, a solution of ~xample 1 Part M 5,6-e~o epoxy aldehyde (170 mg, 0.62 mmole) in 3 ml of methylene chloride was added slowly. The reaction mixture was stirred at room temperature overnight, whereupon it was diluted with ather and washed with water. The organic layer was dried over anhydrous magnesium sulfake, filtered and concentratred under reduced pre~sure. The c N de oily residue was chromato-graphed on a silica gel column and eluted with15-30% ethyl acetate in hexane to obtain 177 mg of title enone.

-4~-B. [la,2~(5Z),3~(1E,3R,4S),4~,5a,6a]-7-[5,6-Epoxy~ hydroxy-4-phenyl-1-pentenyl)-7-oxabicyclo[2.2.l]hept-2-yl]-5-heptenoic acid! methYl_ester To a solution of 177 mg of Part A enone in 5 ml of dry methanol and s ml of distilled THF was added with stirring 175 mg of ceric (III) chloride hydrate. After 10 minutes at room temperature, the homogeneous solution was cooled to -50OC in dry ice-acetone bath and 20 mg of solid sodium boro-hydride was added with tirring. A~ter 1 hour at -50C, the reaction mixture was quenched by addition of aqueous ammonium chloride solution, warmed to room temperature and was then diluted with ether. The organic layer was separated and the aqueous layer was extracted twice wi~h ether and twice with methylene chloride. The combined organic extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure.
The crude residue was chromatographed on a silica gel column and eluted with 20-50% ethyl acetate in hexane to obtain 133 mg of title alcohol~ester as an oil.

ExamPle 8 [1~,2~5Z),3~(1E,3R,4S),4a,5a,6a]-7-[5,6-Epoxy-3-(3-hydroxy-4-phenyl-1-pentenyl)-7-oxa~icyclo-[2.2.1 ~
A solution of 133 mg Example 7 alcohol-ester (O.32 mmole) in 5 ml of distilled lk~ was treated with 2 ml of lN aqueouC lithium hydroxide solution.
The reaction mixture was stirred at room tempera-ture for 16 hours, whereupon it was carefully -4:L-acidified to pH 1 by addition of lN aqueous hydrochloric acid solutloIl. It was now diluted with ether and the organic layer was separated.
The aqueous layer was extracted with methylene chloride ~X2). The combined organic extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 124 mg crude acid, contaminated with ~15% of a-side chain olefin isomer. Chromatogxaphy on a silica gel column and elution with 1-3% methanol in methylene chloride afforded 51 mg of title acid as an oil.

Anal Calcd for C24H305 ~ 72-33; ~ 7-59 Found: C, 72.32; H, 7.57 Fxam~le 9 [la,2~(5Z),3~(1E,3S),4a,5a,6a~-7-t5,6-Epoxy-3-~3-hydroxy-3-phenyl-1-propenyl)-7-oxabicyclo-t2-2-1lhePt-2-yll-s-heDtenoic acid Following the procedure of Examples 7 and 8 except substituting dimethyl(2-oxo-~-phenyl~-ethyl phosphonate for (+)dimethyl(2-oxo-3-methyl-3-phenyl)propyl phosphonate, acid, the title compound is obtained.

[la,2~(5Z),3~1E,35),4a,5a,6a]~-7-[5,6- poxy-3-(3-hydroxy-4-phenyl-1-butenyl)-7-oxabicyclo-L~ 1 hept-2-yll-s-hlp~c~ acid Following the procedure of E~amples 7 and 8 except substituting dimethyl(2-oxo-4-phenyl)-butyl phosphonate for (+)dimethyl(2-oxo-3-1~7(~8~

methyl 3-phenyl)propyl phosphonate, the title compound is obtained.

Example 11 [1~,2~(5Z),3~(1E,3S~4a,5a,6a]-7-[5,6-Epoxy-3-~3-hydroxy-5-phenyl-1-pentenyl)-7-oxabi-cyclo[2.2.1~hept-2-yl~-5-heptenoic acid, methyl ester A. [la,2~(5Z),3~(1E),4a,5~,6a]-7-[5,6-Epoxy-3-(3-oxo-5-phenyl-1-pentenyl~-7-oxabicyclo[2.2.1~hept-2-yl]-5-heptenoic acid, met~yl ester To a suspension of 135 mg anhydrous lithium bromide (1.56 mmole) in 3 ml of dry methylene -chloride was added with stirring 198 ~l triethylamine (1.42 mmole). 386 mg dime~hyl-(2-oxo-4-phenyl)butyl phosphonate (1.51 mmole) in 1 ml of methylene chloride was now added dropwise. After 30 minutes at room temperature, a solution of Example 1 Part M 5,6-exo-epoxy aldehyde (200 mg, 0.7 mmole) in 3 ml of methylene chloride was added dropwise. The reaction mixture was stirred at room temperature overnight, whereupon it was diluted with ether and washed with water. The organic layer was dried over anhydrous magneisum sulfate and concentrated under reduced pressure. The crude residue was chromatographed on a silica gel column and eluted wi~h 40% ethyl acetate in hexane to obtain 208 mg of title enone.

7~

H~363 B. [la,2~(5Z~,3~(1E,3S3,4~,5~,6~]-7-[5,6-Epoxy-3-(3-hydroxy-5-phenyl-1-pentenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-hoL~ Lid, methx~-~ster To a solution of 208 mg of Part A enone (0.5 mmole) in 1 ml of methanol and 1 ml of methylene chloride was added with stirring 124 mg ceric chlorid~ hydrate. ~fter 10 minutes at room temperature, the homogeneous solution was cooled to ~50C and 19 mg of solid sodium borohydride ~O.5 mmole) was added. The reaction mixture was let stand at -50C for 3 hours, whereupon it was treated with aqueous ammonium chloride ~olution.
The cooling bath was removed and the reaction mixture was diluted with ether. The organic layer was separated and the agueous layer was extracted successively with ether and methylene chloride.
The combined organic e~tract was dried over anhydrous magnesium sulfate and concentrated. The crude residue was chromatographed on a silica gel column and eluted with 40% ethyl acetate in hexane to obtain 114 mg of title fast moving alcohol epimer and 40 mg of slow moving isomer.

Exam~le llA
[1~,2~(5Z),3~(1E,3S),4a,5~,6a]-7-[5,6-Epoxy-3-(3-hydroxy-5-phenyl-1-pentenyl)-7-oxabicyclo[2~2.1~-hePt-2-Y11-5-heptenoic cid A solution of 114 mg of Example 11 ester (0.27 mmole) in 1 ml of THF and 1 ml of lN aqueous lithium hydroxide was stirred at 25~C for 2 hours.
The reaction mixture was concentrated and then 7~

acidified with oxalic acicl solution to p~ 3. It was now extracted with ether (X3). The combined ether extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give 100 mg crude oil. Purifications on preparative silica gel plates (eluting solvent 10%
in methylene chloride) gave 37 mg of title acid.

Anal Calcd for C2~H3005: C, 72-33; H, 7-59 Found: C, 72.10; H, 7.54 Exam~le 12 [la,2~5~),3~(1E,3S)4a,5a,6a]-7-[5,6-Epoxy-3-~3-hydroxy-4-cyclopentyl-1-butenyl~-7-o~abi-cvclo[2.2.1lhept-2-yl]-5-he~tenoic acid Following the procedure of Examples 7 and 8 except substituting dimethyl(2-oxo 3-cyclo-pentyl) propyl phosphonate for ( + ) dimethyl(2-oxo-3-methyl-3-phenyl )propyl phosphonate, the title compound is obtained.

Exam~le 13 [la,2~(5Z),3~(1E,3~)4~,5a,6~]-7-[5,6-Epoxy-3-(3-hydroxy-1,5-hexadienyl)-7-oxabicyclo[2.2.1]-he~t-2-yll-5-heptenoic acid __ Following the procedure of Examples 7 and 8 except substituting dimethyl(2-oxo-4-pentenyl)-phosphonate for ( + ) dimethyl (2 oxo-3-methyl-3-phenyl)propyl phosphonate, the title compound is obtained.

7~
aA363 ~45-Example 14 [1~,2~(5Z),3~1E,3S)4~,5~,6~]-7-[5,6-Epoxy-3-(3-hydroxy-1-nonenyl)-7-oxabicyclo[2 .2.1]hept-2-vll~5-heptenoic acid Following the procedure of Examples 7 and 8 except substituting dimethyl(2-oxo-octyl)phos-phonate for (+)dimethyl(2-oxo-3 methyl-3-phenyl)-propyl phosphonate, the title co~pound is obtained.

ExamPle 15 [1~,2~(5Z),3~(1E,3S)4a,5a,6a]-7-[5,6-Epoxy-3-(3-hydroxy-1-pentenyl)-7-oxabicyclo[2.2.1]hept-2-yll-5-heptenoic acid Following the procedure of Examples 7 and 8 except substituting dimethyl(2-oxo-butyl)phos-phonate for (~)dimethyl(2-oxo-3-methyl-3-phenyl)-propyl phosphonate, the title compound is obtained.

Exam~le 16 [la,2~(5Z),3~3R,4S),4a,5a,6~]-7-[5,6-Epoxy-3~
(3-hydroxy-4-phenyl-1-pentyl)-7-oxabicyclo[2.2.1]-he~t-2-yll-5-he~tenoic acid A. [la,2~(5Z),3~(3R,4S),4a,5a,6a]-7-[5,6-Epoxy-3~(3~hydroxy-4-phenyl-1-pentyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester To a suspension of 686 mg of purified cuprous bromide (4.8 mmole) in 12 ~1 of dry ~
cooled at 0-5~C is added with stirring 1.35 ml of a 3.5 M solution of red-~l (sodium bis(2-methoxy-ethoxy)aluminum hydride) in toluene dropwise. The solution is stirred at 0-5C for 30 minutes, whereupon it is cooled to -78C and 2 ml of n-butanol (18 mmole) is added rapidly, followed by a solution of 672 mg of Example 7 Part A enone 70 ~

(2 mmole) in 4 ml of dry THF. After 10 minutes at -78C, the reaction mixture is warmed to -20C and left for an additional 1 hour. The reaction mixture is quenched by addition of 70 ml of water and then poured into saturated ammonium chloride solution and extracted with ether (X3). The ether extract is dried over anhydrous magnesium sulfate, filtered and the filtrate is concentrated under reduced pressure. 675 Mg of desired title ketone is obtained.
To a solution of 338 mg of ketone (1 mmole) (prepared aR described above) in 2 ml of methanol and 2 ml of dry THF is added with stirring 400 mg of ceric (III) chloride hydrate (1 mmole).
After stirring at room temperature for 10 minutes, the reaction mixture is cooled to -50C and 38 mg of solid sodium borohydride (~1 mmole) is added to the reaction mixture. The reaction mixture is stirred at -50C for 45 minutes, whereupon 5 ml of acetone is added to destroy excess of borohydride.
The mixture is stirred for an additional 5 minutes at -50C. The cooling bath is removed and the reaction mixture is evaporated to dryness. The crude residue is diluted with ether and washed with 1 N aqueous hydrochloric acid solution. The ether extract is dried over anhydrous MgS04 and concentrated under reduced pressure. The crude residue is chromatographed on a silica gel column and eluted with ethyl acetate (30-50~) in hexane to obtain the desired title alcohol.

B. [la,2~(5Z~,3~(3R,4S),4a,5a,6~]-7-[5,6-Epoxy-3-(3-hydroxy-4-phenyl-1-pentyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-hePtenoic acid H~363 Following the procedure of Example 8 except substituting the above Part A alcohol ester for the Example 7 aicohol ester, the title compound is obtained.

ExamDle 17 rla,2~3(5Z),3~(3S),4~,Sr~,6a]--7--t5,6--Epoxy--3--(3--hydroxy-3-phenyl-1-propyl)-7-oxabicyclot2.2.1]-Following the proc~dure of Example 16 and E~amples 7 and 8 except subs~ituting benzoic acld for 2-phenylpropionic acid, the title compound is obtained.
Exam~le 18 [la,2~(5Z),3~(3S~,4~,5~,6a]-7-~5,5-Epoxy-3~(3-hydroxy 4-phenyl-1-butyl)-7-oxabicyclo[2.2.1]-hept-2-Y11-5-he~tenoic acid Following the procedure of Example 16 and Examples 7 and 8 except substituting phenylacetic acid for 2-phenylpropionic acld, the title compound is obtained. -Exa~ple 19 tla,2~(5Z~,3~(3S),4a,5a,6a~]-7-[5,6-Epoxy-3-(3-hydroxy-3-cyclohexyl-1-propyl~-7-oxabicyclo[2.2.1]-h~ 2-Y11-5-heptenoic acid Following the procedure of Example 16 and Examples 7 and 8 except substituting cyclohexyl-carboxylic acid for 2~phenylpropionic acid, the title compound is obtained.

70 ~

Examples 20 to 29 Following the procedure of Examples 7 and 8 (where A is CH=CH) and Example 16 (where A is ( CH2 )2 ), except substitut.ing for carboxybutyl-5 triphenylphosphonium bromide, the compound shown in Column I of Table I set out below and substituting for (+)dimethyl(2-oxo-3 -methyl-3-phenyl)propyl phosphonate, the compound shown in Column II, the compound of the invention ~hown in Column III
10 is obtained.

1~7~

a' ''~ C b ~o~

~o -s ~3~ ~ rr',~aSrO b~

-~ 21 q ~ ~ ~ `J Ui ~7~

t- ~ E ¦ ~ ~

X

zl o~

E~A3 63 Example 3 0 [la,2~(5Z),3~1E),4~,5a,6~]-7-[5,6-~poxy-3-[3-hydroxy-3~(1-methylcyclohexyl)~1-propenyl]-7-oxabicyclo[2.2.1]hept-2-yl]~5-heptenoic acid, methyl ester _ .
A. [la,2~(5Z),3~(1E),4a,5a,6a]-7-[5,6-Epoxy-~-[3-oxo-3-(1-methylcyclohexyl)-1-propenyl]-7-oxabicyclot2.2.1]hept-2-yll-5-heptenoic acid, me~hYl ester To a sl~rry of 135 m~ of lithium bromide (1.56 mmole, 2.2 equiv.) in 3 ml of dry methylene chloride at 25C was added a solution of 293 mg of dimethyl t2-~l-methylcyclohexyl)]-2-oxo-ethyl phosphonate (1.5 mmole, 2.1 equiv.) in 1 ml of methylene chloride and 198 ml of triethylamine (1.42 mmole, 2.01 equiv.). After stirring for 30 minutes, a solutio~ Of ca. 0.70 mmole of ~la,2~-(5Z),3,B(lE:),4~,5a,6c~3-7-tS,6-epoxy- -formyl-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, 20 methyl ester (prepared as described in Example 1 Part M) in 1 ml of methylene chloride was added.
The stirring was continued at 25C for 18 hours.
The reaction mixture was then treated with S ml of lM NaE~2P04 solution and diluted with 30 ml of 25 ether. The layers were separated. The organic layer was washed with 10 ml of a saturated K~CO3 solution, 10 ~1 of ~2 and 10 ml of brine. The or~anic layer was then dried (MgSO4~ and concentrated.
The residue was purified on a silica gel colu~ul. Elution with 25% EtOAc/hexane gave 170 mg of title enone as a clear oil.

1~7~

~A363 B. [1~,2~(5Z),3~(1E,3S),4a,5~,6~] 7-~5,6-Epoxy-3-~3 hydroxy-3-(l-methylcyclo-hexyl) l-propenyl]-7-oxabicyclo-[2.2.1]hept-2-yl]-5-heptenoic acid, methYl ester _ _ To a solution of 170 mg of Part A enone ~0.42 mmole~ in 1 ml of methanol and 1 ml of THF
at 25c was added 102.9 mg of cerium trichloride ~0.42 mmole, 1 equiv.). After stirring at 25c for 15 minutes, the mixture was cooled to -50c and 15.9 mg of sodium borohydride 6.42 mmole, 4 eguiv. was added, The mixture was stirred at -50C for 3 hours, then poured into 30 ml of a saturated solution of ammonium chloride. The aqueous solution was extracted with three 15 ml portions of ether. The combined extract was wsahed with 10 ml of H20, dried (MgS04) and concentrated. The residue was purified on a silica gel column. Elution with 25% of EtOAc/hexane gave 128 mg of title alcohol ester.

Example 31 la,2~(5Z),3~(1E,3S),4a,5~,6a]-7-[5,6-Epoxy-3-[3-hydroxy-3-(1-methylcyclohexyl)-1-propenyl]-7 oxabicvclo[2.2.1lheDt-2-yll-5-heptenoic acid A mixture of 128 mg of Example 30 alcohol ester (O.31 mmole), 1 ml of lN LiOH (l.O mmole, 3 equiv.) in 1 ml of THF was stirred a~ 25C for 2 hours and then concentrated. The residue was diluted with 5 ml of H20, acidifying to pH 3 with a saturated solution of oxalic acid, then extracted with three 15 ml portions of ether. Th~
combined ethereal extract was washed with 15 ml of 7~ ~4 ~

H20, dried (MgS04) and concentrated ~o give 112 mg of a crude oil, This oil was purified on a silica gel preparative plate (50 mg batches, 0.5 mm silica gel plate, 10~ MeOH/CH2C12) to yield a total Of 49.6 mg of clean acid product.

TLC: silica gel; 10% MeOH/C~2Cl2; Rf ~ 0.60 Anal Calcd for C23H345- 5 H20 H, 8.82 Found: C, 69.10; H, 8.51 Example 32 [la,2~(5Z),3~(1E,35),4a,5~,6~]-7-[5,6-Epoxy-3-(3-hydroxy-4,4-dimethyl-1-octenyl)-7-oxabicyclo~2.2.13-he~t-2-Yll-5-heptenoic_acid, methvl ester A. [la,2~(5Z),3~(1E),4a,5a,6a]-7-[5,6-Epoxy-3-(3-oxo-4,4-dimethyl-1-octenyl)-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methYl ester To a sluxry of 102 mg of lithium bromide (1.17 mmol, 2.2 equiv.) in 3 ml of dry CH2C12 at 25C was added a solution of 293 mg of 3,3-dimethyl-2-oxo-heptyldimethylphosphonate (1.11 ~mole, 2.1 eguiv.) in 1 ml of CH2C12 and 14B
ml of triethyl~mine (1.06 mmole, 2.01 eguiv.).
After stirring at 25C for 30 minutes~ a solution of ca. 0.53 mmole of [la,2~(5Z),3~(1E),4a,5a,6a]-7-[5,6-epoxy-3-formyl-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, methyl ester (prepared as described in Example 1 Part M) in 1 ml of CH2Cl2 was added. The stirring was continued at 25C for 1i~7(3~

18 houxs. The reaction mixture was then treated with 5 ml of lM NaH2P04 solution, and diluted with 30 ml of ether. The layers were separated. The organic layer was washed with 1 ml of a saturated KHC03 solution, 10 ml o H20 and 10 ml of brlne.
The organic layer was then dried (MgS04) and concentrated.
The residue was purified on a silica gel column. Elution with 25~ EtOAc/hexane gave 130 mg of title enone as a clear oil.

B. [la,2~(5Z),3~(1E,3S),4a,5a,6a]-7-[5,6-Epoxy-3-(3-hydroxy-4,4-dimethyl-1-octenyl)-7-oxabicyclo[2.2.13hept-2-yl]-5-hePtenoic acid, methyl ester To a solution of 130 mg of Part A enone (0.32 mmole) in 1 ml of methanol and 1 ml of THF
at 25C was added 78.4 mg of cerium trichloride 0.32 mmole, 1 eguiv.). After stirring at 25C for 15 minutes, the mixture was cooled to -50C and 12.1 mg of sodium borohydride (0.32 mmole, 4 equiv.) was added. The mixture was stirred at -50C for 3 hours, then poured into 30 ml of a saturated solution of ammonium chloride. The aqueous solution was extracted with three 15 ml portions of ether. The combined extract was washed with 10 ml of H20, dried (MqS04) and concentrated. Ths residue was purified on a silica gel column. Elution with 25% EtOAc/hexane gave 96 mg of title alcohol ester.

L~

Exam~le 33 [la,2~(5Z~,3~(1E,~S),4a,5~,6~]-7-[5,6-Epoxy-3-(3-hydroxy-4~ 4-dimethyl-1-octenyl)-7-oxabicyclo-r2.2.11he t-2-yll-5-he tenoic acid P
A mixture ~f 96 mg of Example 31 alcohol ester (~.23 mmole), 1 ml of lN Lio~ (l.o mmole, 4 eguiv.) in 1 ml of THF was stirred at 25C for 2 hours, then concentrated. The residue was diluted with S ml of ~2~ acidifying to pH 3 with a 10 saturated solu~ion of oxalic acid, then extracted with three 15 ml portions of ethex. The combined ethereal extract was washed with 15 ml of H20, dried ~MgSO4) and concentrated to give 75 mg of a crude oil.
This oil was purified on ~ilica gel preparative plate~ (50 mg batches; 0.5 mm plates;
10% MeOH (CH2C12) to yield a total of 49.8 mg of clean acid product.

TLC: silica gel; 10% MeOH/CH2CH2; Rf ~ 0.55 Anal Calcd for C23H3605: C, 70.37; H~ 9.~4 Found: C, 70.34; H, 9.43

Claims (5)

The embodiments of the invention in which an exclusive property or privilege is claimed are de-fined as follows:
1. A compound having the structure CH2-CH=CH-(CH2)m-CO2alkyl wherein X is -CH2-C , -CH2OH, -CHO or -CH=CH-?-R1 wherein m is 1 to 5, and R1 is lower alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl or lower alkenyl.
2. The compound as defined in claim 1 having the structure CH2-CH=CH-(CH2)m-CO2alkyl wherein m is defined as in claim 1.
3. The compound as defined in claim 1 having the structure wherein m is defined as in claim 1.
4. The compound as defined in claim 1 having the structure wherein m is defined as in claim 1.
5. The compound as defined in claim 1 having the structure wherein m and R1 are defined as in claim 1.
CA000595287A 1985-05-21 1989-03-30 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs Expired - Lifetime CA1270842A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000595287A CA1270842A (en) 1985-05-21 1989-03-30 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US736,628 1985-05-21
US06/736,628 US4611005A (en) 1985-05-21 1985-05-21 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombotic disease
CA 507060 CA1270842C (en) 1985-05-21 1986-04-18 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs
CA000595287A CA1270842A (en) 1985-05-21 1989-03-30 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA 507060 Division CA1270842C (en) 1985-05-21 1986-04-18 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs

Publications (1)

Publication Number Publication Date
CA1270842A true CA1270842A (en) 1990-06-26

Family

ID=25670964

Family Applications (2)

Application Number Title Priority Date Filing Date
CA000595286A Expired - Lifetime CA1271198A (en) 1985-05-21 1986-04-18 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs
CA000595287A Expired - Lifetime CA1270842A (en) 1985-05-21 1989-03-30 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA000595286A Expired - Lifetime CA1271198A (en) 1985-05-21 1986-04-18 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs

Country Status (1)

Country Link
CA (2) CA1271198A (en)

Also Published As

Publication number Publication date
CA1271198C (en) 1990-07-03
CA1271198A (en) 1990-07-03

Similar Documents

Publication Publication Date Title
CA1215063A (en) 7-oxabicycloheptane and 7-oxabicycloheptene compounds
CA1214178A (en) 7-oxabicycloheptane substituted prostaglandin interphenylene analogs
CA1257286A (en) 7-oxabicycloheptane substituted thio prostaglandin analogs
CA1213597A (en) 7-oxabicycloheptane thio ethers
CA1262737A (en) 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs
CA1213598A (en) 7-oxabicycloheptane substituted prostaglandin analogs
CA1249292A (en) 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease
CA1249290A (en) 7-oxabicycloheptane ethers
CA1249293A (en) 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease
US4591603A (en) 7-oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombotic disease
CA1249289A (en) 7-oxabicycloheptane substituted thio prostaglandin analogs
CA1262140A (en) 7-oxabicycloheptane substituted prostaglandin alcohols
CA1257285A (en) 7-oxabicycloheptane substituted oxa prostaglandin analogs
CA1270842A (en) 5,6-epoxy-7-oxabicycloheptane substituted prostaglandin analogs
GB2136428A (en) 7-Oxabicycloheptane Substituted Prostaglandin Analogs
CA1256888A (en) 7-oxabicycloheptane substituted oxa prostaglandin analogs
US4575512A (en) 7-Oxabicycloheptane substituted oxa prostaglandin analogs and their anti-thrombotic compositions and methods
CA1262912A (en) Tetrahydrofuranyl substituted prostaglandin analogs
EP0150710A2 (en) 7-Oxabicycloheptane prostaglandin analogs
CA1267150A (en) Thiabicycloheptane substituted amino prostaglandin analogs
US4588742A (en) Thiabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombotic disease
CA1249287A (en) 7-oxabicycloheptane-substituted oxa prostaglandin analogs
EP0183238A2 (en) 7-Oxabicycloheptane substituted oxa prostaglandin analogs
US4626548A (en) 7-oxabicycloheptane substituted prostaglandin compounds useful in the treatment of thrombotic disease
CA1257287A (en) 7-oxabicycloheptane substituted thio prostaglandin analogs

Legal Events

Date Code Title Description
MKLA Lapsed